1-3 of 3
D Oette
Close
Sort by
Journal Articles

A randomized placebo-controlled phase III study of granulocyte- macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)

JM Rowe, JW Andersen, JJ Mazza, JM Bennett, E Paietta, FA Hayes, D Oette, PA Cassileth, EA Stadtmauer, PH Wiernik
Journal: Blood
Blood (1995) 86 (2): 457–462.
https://doi.org/10.1182/blood.V86.2.457.bloodjournal862457
Published: 1995
Journal Articles

Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group Trial

HM Lazarus, J Andersen, MG Chen, D Variakojis, EG Mansour, D Oette, CA Arce, MM Oken, SL Gerson
Journal: Blood
Blood (1991) 78 (3): 830–837.
https://doi.org/10.1182/blood.V78.3.830.830
Published: 1991
Journal Articles

Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection [see comments]

JM Pluda, R Yarchoan, PD Smith, N McAtee, LE Shay, D Oette, M Maha, SM Wahl, CE Myers, S Broder
Journal: Blood
Blood (1990) 76 (3): 463–472.
https://doi.org/10.1182/blood.V76.3.463.463
Published: 1990